Marcelo Alves Soares

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biologia

Departamento:

Departamento de Genética/IB

ORCID:

não disponível no Lattes


Formação:

  • Insitut Pasteur de Paris

    | Pós-Doutorado | 2000 - 2001

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Genética) | Doutorado | 1993 - 2000

  • Universidade Federal do Rio de Janeiro

    Biofísica | Mestrado | 1991 - 1993

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas - Bacharelado Em Genética | Graduação | 1987 - 1990
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
Nenhum artigo cadastrado
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Mutations associated to antiviral drug resistance in the NS3 and NS5B genomic regions in of HCV genome in treatment-naïve treatment patients from Southern Brazil 2013
Estimated genetic barrier for newly characterized resistance mutations in the C-terminal RT domains in different HIV-1 subtypes 2011
Further evidence of PCR contamination with murine DNA during detection of XMRV-like sequences from patients with prostate cancer and HIV infection: a Latin American survey 2011
Analysis of the expression levels of the viral restriction factor RIG-I and the ubiquitin ligases RNF-125 and TRIM25 in health and HIV-infected individuals 2011
Genetic diversity of human papillomavirus among HIV+ pregnant women in Rio de Janeiro, Brazil 2011
Viral diversity and transmission chains of HIV-1 in a prison of soouthern Brazil 2011
Funcional impact of polymorphisms in alpha-4 subunit gene from alpha-4 beta-7 integrin in HIV-positive patients 2011
Primary resistance evaluation in HIV-1 connection and RNase H regions in HIV/AIDS patients from Rio de Janeiro 2011
DISCORDANT GENOTYPIC INTEREPRETATION AND PHENOTYPIC ROLE OF PROTEASE MUTATIONS IN HIV-1 SUBTYPES B AND G 2009
On the origin of HIV-1 subtype C in South America 2008
Prevalence of Primary HIV-1 Drug Resistance among HIV-positive Treatment-Naïve Cameroonians 2008
NRTI treatment-related variations in conection and RNase H RT domains and their relation with accumulation of thymidine analogue mutations 2008
INTER-SPECIFIC GENETIC VARIATION IN THE B30.2 DOMAIN OF TRIM5a GENE FROM NEOTROPICAL MONKEYS 2008
Differential Resistance Mutation and Polymorphism Acquisition in HIV-1 Protease of Subtypes B and F1 from Children and Adult Patients 2008
Extensive genetic variation in the B30.2 domain of TRIM5a gene from neotropical primates 2008
Conservation patterns of HIV-1 RT connection and RNase H domains: identification of new antiretroviral-associated mutations 2007
Differential Drug Resistance Acquisition in HIV-1 of Subtypes B and C 2007
Epidemiologic and Evolutionary Trends of HIV-1 CRF31_BC-Related Strains in Southern Brazil 2007
On the origin of HIV-1 Subtype C in Brazil 2007
Evolution of Cyclophilin A and TRIMCyp Retrotransposition in New World Primates 2006
WATCH: A worldwide database for collecting and analysing data on transmission of drug resistant HIV using standardized methods 2006
Molecular evidence of a new circulating recombinant form (CRF) comprising human immunodeficiency virus type 1 subtypes C and B in southern Brazil 2006
Evidence for an increase in the prevalence of human immunodeficiency virus type 1 CRF02_AG in Rio de Janeiro, Brazil 2006
Phenotypic analysis of T74S polymorphism in the protease of HIV-1 of B and C subtypes 2006
WATCH: Worldwide Analysis of Resistance Transmission over Time of Chronically and Acute Infected HIV-1 infected persons 2006
Global transmission of resistant HIV-1: geographical patterns may reflect differences in introduction and use of antiretroviral drugs 2006
Detecção de Potenciais Mutações de Resistência na Região da RNase H do HIV-1 dos Subtipos B e C 2006
Análise do fator de restrição TRIMCYP na infecão por HIV-1 em primatas neotropicais do gênero Aotus 2005
Applying Baysian networks to study nelfinavir resistance pathways in subtypes A, B, C, F and G 2005
Mother-to-child transmission of minority HIV-1 drug resistant strains 2005
Differential temporal evolution of drug resistance mutations in HIV-1 of B and C subtypes 2005
Role of HIV-1 protease residues 71 and 89 in protease inhibitor resistance of subtype G viruses 2005
Interactions between nevirapine resistance mutations and NRTI resistance mutations 2005
Mapping nevirapine and efavirenz resistance using Bayesian networks of HIV-1 pol sequences of subtypes A, B, C, F and G 2005
Selection of resistance following first-line antiretroviral regimens among HIV-1 subtypes 2005
Biological characterization of HIV-1 subtype C protease carrying indinavir drug resistance mutations 2005
HIV-1 subtype C dissemination in southern Brazil 2005
Analysis of TRIMCypA restriction factor among New World monkeys (Platyrrhini, Primates) 2005
Development of high resistance to NNRTIs during therapy with 2 NRTIs in HIV-infected children 2005
The influence of Taxon sampling on the bootstrap value supporting Brazilian HIV-1 subtype C monophyly 2005
HIV genetic variation and evolution of antiretroviral drug resistance 2005
Comparison of Protease Drug Resistance Mutations and other Polymorphisms in Brazilian Patients Infected With F1 HIV-1 Variants and Matched Brazilian Patients Infected With HIV-1 Subtype B 2005
Desenvolvimento de Metodologia de Detecção Simultânea por ?Real-Time PCR? de Co-Infecções por HIV-1/HIV-2 2005
DBCollHIV: A Database for HIV Collaborative Analysis in Brazil 2005
BAYESIAN NETWORK REVEALS LINKAGE FOR MUTATIONS AT POSITION 89 OF HIV-1 PROTEASE TO OTHER PROTEASE CODONS AND THERAPY WITH PROTEASE INHIBITORS 2004
Contrasting subtype-treatment interaction in HIV-1 subtypes: differences in subtypes B and C reverse transcripase (RT) and protease (PR) genotypic evolution 2004
Impact of Nelfinavir Resistance Mutations on In Vitro Phenotype, Fitness and Replication Capacity of HIV-1 with Subtype B and C Proteases 2004
Evaluation of Four Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors in HIV-1 Non-B Subtypes 2004
Disease progression and prevalence of drug resistance mutations in drug-naïve subjects infected with different HIV-1 subtypes in the army health service in Rio de Janeiro, Brazil 2004
HIV-1 protease and RT mutations according to subtype and antiretroviral therapy: A watch list for epidemiologic studies using a web-based application 2004
Higher selective pressure on V3 crown of HIV-infected children with longer survival 2004
HIV-1C subtype in Southern Brazil seems to be two times more infectious than HIV-1B 2004
Alternative, age-related routes of nelfinavir resistance in HIV type 1-infected children under highly active antiretroviral therapy 2004
Impact of Nelfinavir resistance mutations on the human immunodeficiency virus type 1 with subtypes B and C proteases 2004
Em busca de uma nova forma recombinante circulante do HIV-1 no sul do Brasil 2004
TAXAS DIFERENCIAIS DE ACÚMULO DE MUTAÇÕES DE RESISTÊNCIA AOS ANTI-RETROVIRIAS EM VÍRUS DA IMUNODEFICIÊNCIA HUMANA DO TIPO 1 DOS SUBTIPOS B E C 2004
Global Mapping of HIV-1 Drug Resistance Patterns 2003
The Recently Introduced HIV-1 Subtype C in Brazil Appears to be Two Times More Infectious than HIV-1 B Subtype 2003
Genotypic Analysis of RT and Protease sequences from persons infected with non-subtype B viruses 2003
Characterization of human immunodeficiency virus type 1infection in Porto Alegre, Brazil 2003
DC-SIGN from African Green Monkeys enhances SIVagm infection in cis and mediates infection in trans 2003
Fonctions virologiques de DC-SIGN du singe vert d'Afrique : implications dans l'infection non pathogène SIVagm 2003
HIV drug resistance mutations in ARV-treated patients from southern Brazil 2003
Synonymous genetic changes within subtype F HIV-1 may influence mutational routes to drug resistance 2003
Comparison of five interpretation algorithms for the prediction of protease inhibitor susceptibility in HIV-1 non-B subtypes 2003
Nucleic acid differences between HIV-1 non-B and B reverse transcriptase and protease sequences at drug resistance positions 2003
Epidemiologic and molecular characterization of of human immunodeficiency virus type 1 in Southern Brazil 2003
In vitro susceptibility to protease inhibitor from subtype C of human immunodeficiency virus type 1 isolates 2003
In vitro susceptibility to protease inhibitors from subtype C of human immunodeficiency virus type 1 isolates 2003
Influence of HIV-1 subtype for vertical transmission in pregnant women in the city of Rio Grande, RS, Brazil 2003
Prevalence of subtype C in pregnant women, Rio Grande, RS, Brazil 2003
Contribution des singes verts d'Afrique, modèle d'étude de la résistance au SIDA, dans la compréhension des intreactions lentivirus-cellules dendritiques 2003
The subtype C of human immunodeficiency viruses type 1 circulating in Brazil an South Africa presents a hypersusceptibiity to protease inhibitor lopinavir 2003
Evolution of CCR5 gene in Platyrrhini, Primates and its implication on resistance to lentiviruses 2003
Prevalence of HIV-1 subtypes among vertically-infected children in Rio de Janeiro, RJ, Brazil 2003
Prevalence of subtype C of human immunodeficiency virus type 1 and its influence on mother-to-child transmission in the city of Rio Grande, RS, Brazil 2003
Genetic polymorphisms in protease and reverse transcriptase of Brazilian HIV-1 subtypes and their influence on drug resistance 2003
Impact of nelfinavir-resistance mutation in in vitro phenotype, fitness and replication capacity of human immunodeficiency virus type 1 B and C subtypes 2003
The subtype C of human immunodeficiency virus type 1 accumulates known drug resistance mutations at a slower rate than subtype B counterparts 2003
Caracterização Molecular dos Vírus da Imunodeficiência Humana do Tipo 1 na Cidade Portuária de Rio Grande, RS 2003
Perfil de Subtipos e de Resistência à Drogas de Vírus da Imunodeficiência Humana do Tipo 1 em Portadoresd e HIV/AIDS da Cidae de Porto Alegre, RS 2003
Rede Brasileira de Vigilância de Resistência Medicamentosa do HIV (REVIRE): Resultados do Primeiro Levantamento Nacional 2003
Identification of a specific subtype C of human immunodeficiency virus type 1 in Brazil: implications on highly active antiretroviral treatment 2003
DC-SIGN from African green monkeys is an efficient attachment factor for SIVagm 2003
Identification of a specific subtype C of human immunodeficiency virus type 1 in Brazil: implications on highly active antiretroviral treatment 2002
Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): results from the first national survey 2002
EVOLUÇÃO DO GENE DO RECEPTOR DE QUIMIOCINA DO TIPO 5 (CCR5) EM PRIMATAS DO NOVO MUNDO (Platyrrhini, Primates): IMPLICAÇÕES NA SUSCEPTIBILIDADE A LENTIVÍRUS 2002
Interaction entre SIVagm et DC-SIGN du singe vert d'Afrique 2002
Requerimento da integridade N- e C-terminal para a função da IN do HIV-1 2001
Étude du lien entre la résistance au SIDA et la dynamique de réplication virale lors de la phase aiguë de l'infection SIVagm chez le singe vert d'Afrique 2000
Role of dendritic cells (DC) in the dissemination of SIVagm and activation of T-cells in the SIVagm/AGM model 2000
Distinct HIV-1 Strains in the Bone Marrow are Associated with the Development of Thrombocytopenia 1999
HIV-1 Selection in Response to Inhibition of Virus Fusion and Entry 1999
Virulent HIV-1 Strains in the Bone Marrow are Associated with the Development of Thrombocytopenia 1999
Cross-species Transmission of Simian Immunodeficiency Virus from African green monkeys: Virus Evolution in a New Host 1999
Trans Complementation of Integrase function 1998
Trans Complementation of Integrase function 1998
Molecular determinants of HIV-associated thrombocytopenia 1998
A Full Length and Replication Competent Proviral Clone of SIVagm from Tantalus Monkey 1997
Complementation of Integrase Function iin HIV-1 Virions 1997
HIV Accessory Proteins: Tools to Probe the Virus Particle 1997
Serological and molecular Characterization of SIVagm in South Africa 1996
Virion-Associated Accessory Proteins in HIV/SIV: New Tools for Antiviral Therapy? 1996
Antiquity of SIV infection in African Green Monkeys 1995
Structure-function relationships of foot-and-mouth disease virus RNA polymerase: evidence for in vitro cooperation among enzyme molecules 1994
Development of a foot-and-mouth disease virus RNA polymerase with lost activity 1992
In vitro activities of a recombinant foot-and-mouth disease virus replicase expressed in Escherichia coli 1992
Utilização de uma replicase de picornavírus como um alvo de imuniuzação intracelular 1992
In vitro activities of a recombinant foot-and-mouth disease virus replicase expressed in Escherichia coli 1992
Expressão em Escherichia coli do cDNA contendo a sequência completa do gene da RNA polimerase do vírus da febre aftosa 1991
DNA MAP: Uma nova ferramenta para construir mapas de restrição 1989
DNA MAP: Uma nova ferramenta para construir mapas de restrição 1989
Utilização de Técnicas de Engenharia Genética para Controlar a Febre Aftosa 1989
Publicações:
Minha Rede: